Research

Energy balance

GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration compared to SGLT-2 inhibitor use.

Practitioners can consider GLP-1 receptor agonists safe regarding pulmonary aspiration risk before endoscopy.

StrongRefutesmedium confidence
Compared with SGLT-2 inhibitor use, GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration (pooled risk ratio 0.98, 95% CI 0.73 to 1.31).
Wajd Alkabbani et al. · BMJ · 2024

Why this rating

Based on the cohort study design.

Source

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study

Wajd Alkabbani et al. · BMJ · 2024

DOI 10.1136/bmj-2024-080340

cohort · n=43365Cited 51×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →